| Profile | GDS1873 / 209383_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 632.566 | 80 |
| GSM40788 | control - Rep 2 | 549.637 | 79 |
| GSM40789 | control - Rep 3 | 440.795 | 75 |
| GSM40775 | androgen treated - Rep 1 | 411.693 | 73 |
| GSM40776 | androgen treated - Rep 2 | 585.703 | 80 |
| GSM40777 | androgen treated - Rep 3 | 362.366 | 70 |
| GSM40790 | estrogen treated - Rep 1 | 287.863 | 64 |
| GSM40791 | estrogen treated - Rep 2 | 341.284 | 68 |
| GSM40792 | estrogen treated - Rep 3 | 536.981 | 78 |
| GSM40784 | A + tamoxifen - Rep 1 | 368.568 | 70 |
| GSM40785 | A + tamoxifen - Rep 2 | 357.847 | 69 |
| GSM40786 | A + tamoxifen - Rep 3 | 498.124 | 77 |
| GSM40778 | A + anastrozole - Rep 1 | 588.319 | 81 |
| GSM40779 | A + anastrozole - Rep 2 | 351.843 | 68 |
| GSM40780 | A + anastrozole - Rep 3 | 495.76 | 77 |
| GSM40781 | A + letrozole - Rep 1 | 401.07 | 74 |
| GSM40782 | A + letrozole - Rep 2 | 389.889 | 71 |
| GSM40783 | A + letrozole - Rep 3 | 838.018 | 86 |